Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

J&J resumes PFA rollout after review | Cardiovascular care for veterans | A potential new therapy for heart disease

News You Need to Know Today
J&J resumes PFA rollout after review | Cardiovascular care for veterans | A potential new therapy for heart disease
Wednesday, February 19, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Johnson & Johnson resumes PFA rollout after stopping to review safety concerns

Johnson & Johnson MedTech has resumed the U.S. rollout of its Varipulse PFA system, sharing new warnings to help physicians. 

READ MORE >
Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston.
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson resumes PFA rollout after stopping to review safety concerns

Share on Twitter Share on Facebook Share on Linkedin
Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston.
Johnson & Johnson MedTech has resumed the U.S. rollout of its Varipulse PFA system, sharing new warnings to help physicians. 
READ MORE >

Veterans with heart disease often receive better care through VA than they would elsewhere

Military veterans face an increased risk of cardiovascular disease, making it especially important to ensure they receive high-quality care.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Veterans with heart disease often receive better care through VA than they would elsewhere

Share on Twitter Share on Facebook Share on Linkedin
Military veterans face an increased risk of cardiovascular disease, making it especially important to ensure they receive high-quality care.
READ MORE >

Osteoporosis drug shows potential to treat heart disease

Researchers used advanced AI to see if any FDA-approved medications could potentially reverse one of the mutations behind dilated cardiomyopathy. Risedronate, a popular osteoporosis medication, is the one candidate that got the job done.

READ MORE >
pharmaceutical drug approval process
Share on Twitter Share on Facebook Share on Linkedin

Osteoporosis drug shows potential to treat heart disease

Share on Twitter Share on Facebook Share on Linkedin
pharmaceutical drug approval process
Researchers used advanced AI to see if any FDA-approved medications could potentially reverse one of the mutations behind dilated cardiomyopathy. Risedronate, a popular osteoporosis medication, is the one candidate that got the job done.
READ MORE >

Featured Articles

FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.” 

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.” 
READ MORE >

LAAO or DOAC? Mayo Clinic AI helps guide treatment of AFib patients

It can be challenging to know which AFib patients are the best candidates for LAAO. A new algorithm out of Mayo Clinic aims to address that problem. 

READ MORE >
AI artificial intelligence stethoscope doctor
Share on Twitter Share on Facebook Share on Linkedin

LAAO or DOAC? Mayo Clinic AI helps guide treatment of AFib patients

Share on Twitter Share on Facebook Share on Linkedin
AI artificial intelligence stethoscope doctor
It can be challenging to know which AFib patients are the best candidates for LAAO. A new algorithm out of Mayo Clinic aims to address that problem. 
READ MORE >

Opportunistic imaging detects signs of heart disease in lung cancer patients

These findings show that opportunistic imaging could go a long way toward making more patients aware of the cardiovascular risks they face—all without requiring additional scans to be performed. 

READ MORE >
lung cancer pulmonary nodule
Share on Twitter Share on Facebook Share on Linkedin

Opportunistic imaging detects signs of heart disease in lung cancer patients

Share on Twitter Share on Facebook Share on Linkedin
lung cancer pulmonary nodule
These findings show that opportunistic imaging could go a long way toward making more patients aware of the cardiovascular risks they face—all without requiring additional scans to be performed. 
READ MORE >

In Case You Missed It

More than words: AI takes NLP to the next level to identify signs of heart failure

Previous NLP algorithms for heart failure looked for certain words or phrases, but this updated model makes decisions based on clinical context. 

READ MORE >
robot reviewing heart data
Share on Twitter Share on Facebook Share on Linkedin

More than words: AI takes NLP to the next level to identify signs of heart failure

Share on Twitter Share on Facebook Share on Linkedin
robot reviewing heart data
Previous NLP algorithms for heart failure looked for certain words or phrases, but this updated model makes decisions based on clinical context. 
READ MORE >

Key details on the use of ICE to guide structural heart procedures

Scott Lim, MD, details his experience using intracardiac echo to help guide structural heart procedures with or without traditional TEE. One key benefit of ICE, he explained, is its ability to overcome imaging challenges posed by prior cardiac surgeries.

READ MORE >
D. Scott Lim, MD, medical director of the Advanced Cardiac Valve Center, and co-director of the Adult Congenital Heart Disease Center at University of Virginia (UVA) Health in Charlottesville, and an associate professor at the University British Columbia, explains how intracardiac echo (ICE) is increasingly being used to help guide structural heart procedures.
Share on Twitter Share on Facebook Share on Linkedin

Key details on the use of ICE to guide structural heart procedures

Share on Twitter Share on Facebook Share on Linkedin
D. Scott Lim, MD, medical director of the Advanced Cardiac Valve Center, and co-director of the Adult Congenital Heart Disease Center at University of Virginia (UVA) Health in Charlottesville, and an associate professor at the University British Columbia, explains how intracardiac echo (ICE) is increasingly being used to help guide structural heart procedures.
Scott Lim, MD, details his experience using intracardiac echo to help guide structural heart procedures with or without traditional TEE. One key benefit of ICE, he explained, is its ability to overcome imaging challenges posed by prior cardiac surgeries.
READ MORE >

TAVR patients admitted on weekend face greater risk of death, complications

The so-called "weekend effect" seen with other cardiovascular diseases appears to exist for patients with severe aortic stenosis as well. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

TAVR patients admitted on weekend face greater risk of death, complications

Share on Twitter Share on Facebook Share on Linkedin
The so-called "weekend effect" seen with other cardiovascular diseases appears to exist for patients with severe aortic stenosis as well. 
READ MORE >

In Other News

Antibiotics prescriptions: There’s a large-language model for that

Add this to the list of high-risk healthcare activities to which generative AI can contribute: prescribing antibiotics. 

READ MORE >
artificial intelligence AI large language model antibiotics
Share on Twitter Share on Facebook Share on Linkedin

Antibiotics prescriptions: There’s a large-language model for that

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI large language model antibiotics
Add this to the list of high-risk healthcare activities to which generative AI can contribute: prescribing antibiotics. 
READ MORE >

Thousands of staff cut from federal health agencies, including CDC and VA

Elon Musk's Department of Government Efficiency (DOGE) continues to push officials to release workers—and more layoffs could be on the horizon.

READ MORE >
DOGE Coin Elon Musk Cryptocurrency
Share on Twitter Share on Facebook Share on Linkedin

Thousands of staff cut from federal health agencies, including CDC and VA

Share on Twitter Share on Facebook Share on Linkedin
DOGE Coin Elon Musk Cryptocurrency
Elon Musk's Department of Government Efficiency (DOGE) continues to push officials to release workers—and more layoffs could be on the horizon.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

The risks of PFA | FDA's warning after patient death | Cardiac ablations in ASCs | Group wants TAVR changes
How TAVR implant depth impacts outcomes | A closer look at GLP-1 drugs & AFib | BATMAN technique to the rescue
Week in Review: Reprocessed catheters recalled | New payment model almost here | 3-year SMART data | Hypertension drug approved
New payment model on the way | Major recalls could impact care | Policy changes for breakthrough devices
FDA warns public after patient death | Medtronic recalls heart devices | 'Compelling' new PE data | Pushing for TAVR changes
News Alert: Medtronic recalls thousands of surgical devices
New IVL tech overcomes previous limitations | 3-year SMART data looks at TAVR outcomes | Artivion acquires Endospan for $135M

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Page 4
    • Current page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup